Last week, readers were most interested in a story about an MOU between Gene Solutions and NEWCL to establish a lab in Taiwan.

Investors and consultants in the space said that they have seen rising enthusiasm among investors as recent funding rounds ...

Upfront will use the proceeds to accelerate the commercialization of its lateral flow test, called LVOne, for triaging stroke ...

The firm presented data at AACR that showed the test had high accuracy when distinguishing ovarian cancer at early stages.

During a fireside chat at the RBC Healthcare Conference, Bio-Rad's CFO Roop Lakkaraju confirmed the firm's prior guide for 130 basis points of net tariff impact, which Connor McNamera, RBC's moderator ...

NeoGenomics has launched c-MET CDx for NSCLC, an immunohistochemistry companion diagnostic assay for the detection of c-Met overexpression, which is observed in up to half of all patients with ...

An unnamed party has made a bid to acquire Akoya at a price of $1.40 per share, which Akoya said could prove a superior proposal to its planned merger with Quanterix.

Sekisui Diagnostics has launched the OSOM RSV Test, a 15-minute immunochromatographic assay that qualitatively detects nucleoprotein antigens from respiratory syncytial virus. The test is CLIA-waived ...

In vitro diagnostic company Genes2Me (G2M) has appointed John Bishop to its advisory board, where he will help guide the firm's strategic direction, product development, and market expansion ...

Following an executive reset, the Tokyo firm hopes to grow its molecular and immunochemical testing businesses.

NEW YORK – A team led by investigators at Institut Pasteur has commenced work on a new lateral flow assay that could be used to detect the presence of the malaria-causing parasite Plasmodium vivax in ...